Drug Shortage Report for VAN-GABAPENTIN

Last updated on 2018-01-26 History
Report ID 37469
Drug Identification Number 02431424
Brand name VAN-GABAPENTIN
Common or Proper name Gabapentin
Company Name VANC PHARMACEUTICALS INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-01-26
Actual start date 2018-01-26
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-01-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2639 VIKING WAY, UNIT 210
RICHMOND, BRITISH COLUMBIA
CANADA V6V 3B7
Company contact information info@vancpharm.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-01-26 French Compare
v1 2018-01-26 English Compare

Showing 1 to 2 of 2